Shaoxing Minsheng Pharmaceutical Co., Ltd. is a responsible pharmaceutical enterprise engaged in pharmaceutical innovation, R & D and production of high-quality drugs. It was established in August 2002 with a registered capital of RMB 88 million. It is a subsidiary of Hangzhou Minsheng pharmaceutical Holding Group Co., Ltd. The predecessor of Minsheng medicine is the API branch of Hangzhou Minsheng Pharmaceutical Co., Ltd. (Hangzhou Minsheng pharmaceutical factory), which was established in 1926.

The company is located in Yuecheng District, Shaoxing City, adjacent to Hangzhou Ningbo Expressway and Hangzhou Xiaoshan International Airport in the north, with very convenient transportation. The plant covers an area of 233000 square meters. It passed the recognition of "high-tech enterprise" in 2008, established a provincial high-tech enterprise R & D center in 2010, and has obtained 13 national invention patents in China. In January 2017, it was listed on the new third edition, and the stock is referred to as "Minsheng medicine", securities code: 870625. The company produces more than 20 kinds of semi synthetic pharmaceutical raw materials such as alanyl glutamine, praziquantel, thiadiazine series, scopolamine series and vinblastine series. Among them, 9 products have passed FDA certification. The products produced by our company enjoy a high reputation among customers at home and abroad. We have established solid cooperative relations with foreign well-known pharmaceutical enterprises such as Merck, Sanofi Aventis and Eisai. Our products are exported to the United States, Japan, France, Germany and other countries and regions. The company has 590 employees, including 5 doctors. Professional technicians with college degree or above account for more than 30% of the total number of employees. Establish a R & D team and quality assurance team led by the doctor to provide escort for the products. Adhering to the social responsibility of "caring for life and serving public health", the company is committed to the development of the pharmaceutical industry, strive to build a high-quality enterprise in China's pharmaceutical field, provide all-round value-added services for our partners, and forge ahead for the cause of human health.